Ownership history in STEMPOINT CAPITAL LP · 4 quarters on record
This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 15,500 | -105,910 | -87.2% | 0.00% | $10K | — |
| 2025 Q3 | ADDED | 121,410 | +4,631 | +4.0% | 1.16% | $5.8M | — |
| 2025 Q2 | REDUCED | 116,779 | -39,406 | -25.2% | 2.00% | $6.2M | — |
| 2025 Q1 | INITIATED | 156,185 | — | — | 2.02% | $6.3M | — |